China’s WuXi Pharma Tech Shakes Up Its Board After Tumultuous Year
This article was originally published in The Pink Sheet Daily
Executive Summary
The West's financial morass could ultimately prod the world's pharmaceutical giants to outsource more research and development to lower-cost China, and to WuXi PharmaTech, CEO says.